NCT03182335View on ClinicalTrials.gov

Vasopressor SAT Study

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 28, 2014

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Low Blood PressureDeliriumCritical Illness
Interventions
OTHER

sedation awakening trial

vital signs and delirium assessment (CAM-ICU) at baseline then following routine sedation awakening trial. Patient will thus serve as their own control for these interventions

Trial Locations (1)

60637

The University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03182335 - Vasopressor SAT Study | Biotech Hunter | Biotech Hunter